TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 20 filers reported holding TREVI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,769,000 | -37.8% | 1,263,408 | 0.0% | 0.20% | -38.5% |
| Q2 2021 | $2,843,000 | -17.0% | 1,263,408 | 0.0% | 0.32% | -0.6% |
| Q1 2021 | $3,424,000 | +2.8% | 1,263,408 | 0.0% | 0.32% | -35.1% |
| Q4 2020 | $3,330,000 | -39.9% | 1,263,408 | -8.2% | 0.50% | -66.7% |
| Q3 2020 | $5,545,000 | -38.7% | 1,375,907 | 0.0% | 1.50% | -39.4% |
| Q2 2020 | $9,053,000 | +117.8% | 1,375,907 | +8.9% | 2.48% | +43.9% |
| Q1 2020 | $4,157,000 | -12.3% | 1,263,408 | 0.0% | 1.72% | +14.1% |
| Q4 2019 | $4,738,000 | -16.7% | 1,263,408 | 0.0% | 1.51% | -14.1% |
| Q3 2019 | $5,685,000 | -40.0% | 1,263,408 | 0.0% | 1.76% | -27.4% |
| Q2 2019 | $9,476,000 | – | 1,263,408 | – | 2.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 11,370,376 | $24,787,420 | 1.91% |
| Fairmount Funds Management LLC | 5,163,287 | $11,255,966 | 1.35% |
| Opaleye Management Inc. | 1,705,900 | $3,718,862 | 1.21% |
| Frazier Life Sciences Management, L.P. | 6,881,090 | $15,000,776 | 1.00% |
| VR Adviser, LLC | 3,422,397 | $7,460,825 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 927,415 | $2,021,765 | 0.61% |
| Rubric Capital Management LP | 5,684,420 | $12,392,036 | 0.46% |
| Tejara Capital Ltd | 180,227 | $392,895 | 0.22% |
| PFS Partners, LLC | 100,000 | $218,000 | 0.19% |
| WealthTrust Axiom LLC | 93,500 | $203,830 | 0.07% |